Akso Health Group AHG
Annual
Quarterly
FY2026 · ended Mar 31, 2026 · Revenue $13.83M, -6.4% YoY · Filed Jul 23, 2026
Akso Health Group (AHG) files with the SEC under industry code 7389, Services-Business Services, NEC. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $13.8 million and a net loss of $18.7 million. Free cash flow was -$12.8 million. As of Mar 31, 2026 it held $170,572 in cash and investments and $25,132 in total debt.
Revenue
$13.83M
-6.4% vs prior year
Net income
$-18.67M
+86.2% vs prior year
Operating cash flow
$-12.79M
-1186.6% vs prior year
Free cash flow
$-12.79M
-1350.9% vs prior year
EPS
$0.01
-93.8% vs prior year
Dividend per share
None
Shares outstanding
1.66B
+278.7% vs prior year
Net cash
$145,440
FY 2026
Operating margin
-149.7%
FY 2026
Company profile
- Industry
- Services-Business Services, NEC (SIC 7389)
- Listed as
- AHG (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Cayman Islands
- Headquarters
- Qingdao Pilot Free Trade Zone, China
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1702318
- Former names
- Xiaobai Maimai Inc. (until Dec 17, 2021); Hexindai Inc. (until Dec 21, 2020)
Other Services-Business Services, NEC companies
- Visa Inc. V
- Mastercard Inc MA
- Alibaba Group Holding Ltd BABA
- Accenture plc ACN
- Uber Technologies, Inc UBER
- PDD Holdings Inc. PDD
- Mercadolibre Inc MELI
- DoorDash, Inc. DASH
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Mar 31, 2026 |
FY 2025 Mar 31, 2025 |
FY 2024 Mar 31, 2024 |
FY 2023 Mar 31, 2023 |
FY 2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $13.8M | $14.8M | $2.4M | $13.2M | $6.0M |
| Operating income | -$20.7M | -$166.3M | -$8.6M | -$14.3M | -$3.3M |
| Net income | -$18.7M | -$135.0M | -$9.5M | -$1.4M | -$16.9M |
| Diluted EPS | $0.01 | $0.16 | $0.07 | -$0.02 | -$0.28 |
| Operating cash flow | -$12.8M | $1.2M | $1.4M | -$3.3M | -$8.6M |
| Free cash flow | -$12.8M | $1.0M | — | — | -$8.6M |
| Total assets | $189.6M | $215.0M | $142.0M | $20.5M | $62.8M |
| Total liabilities | $8.7M | $15.8M | $3.6M | $11.6M | $50.5M |
| Stockholders' equity | $180.9M | $199.1M | $138.4M | $8.7M | $12.3M |
| Cash and investments | $170,572 | $176.2M | $85.2M | $7.9M | $18.4M |
| Total debt | $25,132 | $81,737 | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Jul 23, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | May 13, 2026 | May 13, 2026 |
| 6-K | Current report (foreign issuer) | Mar 23, 2026 | Mar 23, 2026 |
| 6-K | Current report (foreign issuer) | Feb 10, 2026 | Sep 30, 2025 |
| 20-F | Annual report (foreign issuer) | Aug 14, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | May 1, 2025 | May 1, 2025 |
All 195 Akso Health Group SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.